Expert Opinion on Pharmacotherapy

Pharmacogenetics of chronic cardiovascular drugs: applications and implications
pp. 1417-1427(11)
Authors: Zineh, Issam; Johnson, Julie A

Pharmacogenetics of schizophrenia
pp. 1429-1440(12)
Authors: Reynolds, Gavin P; Templeman, Lucy A; Godlewska, Beata R

Injectables for the treatment of stress urinary incontinence: current use and future perspectives
pp. 1441-1447(7)
Authors: Perimenis, Petros; Giannitsas, Konstantinos

Controlling multiple-drug-resistant organisms at the hospital level
pp. 1449-1455(7)
Author: Ramirez, Julio A

Treating osteoporosis: economic aspects of bisphosphonate therapy
pp. 1457-1467(11)
Authors: Kennedy, Courtney C; Papaioannou, Alexandra; Adachi, Jonathan D

Pegylated liposomal doxorubicin in the treatment of cancers of the breast and ovary
pp. 1469-1474(6)
Author: Markman, Maurie

Samarium for osteoblastic bone metastases and osteosarcoma
pp. 1475-1486(12)
Author: Anderson, Pete

Bosentan for the treatment of systemic sclerosis-associated pulmonary arterial hypertension, pulmonary fibrosis and digital ulcers
pp. 1487-1501(15)
Authors: Jain, Manu; Varga, John

Sumatriptan: update and review
pp. 1503-1514(12)
Authors: Cady, Roger; Schreiber, Curtis

After the failure of citalopram for depression, what next?
pp. 1515-1518(4)
Author: Doggrell, Sheila A

7th International Workshop on Clinical Pharmacology of HIV Therapy
pp. 1519-1533(15)
Authors: Kakuda, Thomas N; Kiser, Jennifer J

Corrigendum
pp. 1539-1539(1)